Displaying 41 to 60 of 143 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Cadent Medical Corp Life-saving external defibrillators |
United States | N/A |
||
|
|
Calixa Therapeutics Inc Focused on developing, acquiring and commercializing hospital-based anti-infective therapies. |
United States | N/A |
||
|
|
Cardiac Science Corp Life-saving external defibrillators |
United States | N/A |
||
|
|
Cardio Polymers Inc Biopharmaceutical company focused on non-destructive treatments for cardiac conduction abnormalities. |
United States | N/A |
||
|
|
Carticept Medical Inc |
United States | N/A |
||
|
|
Cartiva Inc Development of medical devices to treat knee and small joint disease |
United States | N/A |
||
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 Sep 2010 | Series D Active |
|
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 May 2005 | N/A Active |
|
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 Jul 2008 | Series C Active |
|
|
|
Cell Biosciences Inc |
United States | N/A |
||
|
Chromacode Inc High-definition PCR technology which enhances the multiplexing capabilities on existing hardware. |
United States | 11 May 2020 | Series C Initial investment. Round participant. Active |
|
|
|
Clovis Oncology Inc |
United States | 1 May 2009 | Series A Active |
|
|
|
CoDa Therapeutics Inc Development and commercialization of wound care therapeutics based on gap junction modulation. |
United States | N/A |
||
|
|
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. |
United States | 1 Aug 2011 | N/A |
|
|
|
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. |
United States | 1 Jan 2006 | Series A |
|
|
|
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. |
United States | 1 Jan 2008 | Series B |
|
|
|
Conforma Therapeutics Corp Novel drugs company for the selective treatment of cancer. |
United States | N/A |
||
|
|
Connetics Corp |
United States | N/A |
||
|
|
Corridor Pharmaceuticals Inc |
United States | N/A |
||
|
|
Dicerna Pharmaceuticals Inc |
United States | N/A |